Published in Mol Biochem Parasitol on January 01, 2002
The P domain of the P0 protein of Plasmodium falciparum protects against challenge with malaria parasites. Infect Immun (2004) 0.94
Arrest of nuclear division in Plasmodium through blockage of erythrocyte surface exposed ribosomal protein P2. PLoS Pathog (2012) 0.86
Cloning and characterization of the acidic ribosomal protein P2 of Cryptosporidium parvum, a new 17-kilodalton antigen. Clin Vaccine Immunol (2010) 0.80
Nature-inspired novel drug design paradigm using nanosilver: efficacy on multi-drug-resistant clinical isolates of tuberculosis. Curr Microbiol (2010) 0.78
Erythrocytic stage-dependent regulation of oligomerization of Plasmodium ribosomal protein P2. J Biol Chem (2012) 0.77
Vaccination with Leishmania infantum acidic ribosomal P0 but not with nucleosomal histones proteins controls Leishmania infantum infection in hamsters. PLoS Negl Trop Dis (2015) 0.76
Translational regulation in blood stages of the malaria parasite Plasmodium spp.: systems-wide studies pave the way. Wiley Interdiscip Rev RNA (2016) 0.75
Plasmodium riboprotein PfP0 induces a deviant humoral immune response in Balb/c mice. J Biomed Biotechnol (2012) 0.75
Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell (2008) 5.53
Safety and efficacy of RNAi therapy for transthyretin amyloidosis. N Engl J Med (2013) 3.97
A plant homeodomain in RAG-2 that binds Hypermethylated lysine 4 of histone H3 is necessary for efficient antigen-receptor-gene rearrangement. Immunity (2007) 3.54
Regulation of microRNA expression and abundance during lymphopoiesis. Immunity (2010) 3.29
Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nat Nanotechnol (2012) 3.09
RNA interference in protozoan parasites. Cell Microbiol (2004) 2.29
Two forms of loops generate the chromatin conformation of the immunoglobulin heavy-chain gene locus. Cell (2011) 1.94
Immune surveillance and therapy of lymphomas driven by Epstein-Barr virus protein LMP1 in a mouse model. Cell (2012) 1.59
miR-150 regulates the development of NK and iNKT cells. J Exp Med (2011) 1.53
Immunoglobulin switch mu sequence causes RNA polymerase II accumulation and reduces dA hypermutation. J Exp Med (2009) 1.52
Distinct Th1- and Th2-Type prenatal cytokine responses to Plasmodium falciparum erythrocyte invasion ligands. Infect Immun (2005) 1.26
Malaria parasite-infected erythrocytes inhibit glucose utilization in uninfected red cells. FEBS Lett (2005) 1.06
Protective properties and surface localization of Plasmodium falciparum enolase. Infect Immun (2007) 1.04
Plasmodium falciparum enolase: stage-specific expression and sub-cellular localization. Malar J (2009) 1.04
Harnessing a physiologic mechanism for siRNA delivery with mimetic lipoprotein particles. Mol Ther (2012) 1.04
A rapid two-step method for isolation of functional primary mouse hepatocytes: cell characterization and asialoglycoprotein receptor based assay development. Cytotechnology (2011) 0.99
Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: Nanoject. Int J Pharm (2008) 0.97
Cloning, over-expression, purification and characterization of Plasmodium falciparum enolase. Eur J Biochem (2004) 0.96
Localized epigenetic changes induced by DH recombination restricts recombinase to DJH junctions. Nat Immunol (2012) 0.95
Measuring erythrocyte deformability with fluorescence, fluid forces, and optical trapping. J Biomed Opt (2009) 0.94
The P domain of the P0 protein of Plasmodium falciparum protects against challenge with malaria parasites. Infect Immun (2004) 0.94
Development of SMEDDS using natural lipophile: application to beta-Artemether delivery. Int J Pharm (2008) 0.92
Glycolysis in Plasmodium falciparum results in modulation of host enzyme activities. J Vector Borne Dis (2006) 0.91
Alterations in urine, serum and brain metabolomic profiles exhibit sexual dimorphism during malaria disease progression. Malar J (2010) 0.90
Novel roles for ATP-binding cassette G transporters in lipid redistribution in Toxoplasma. Mol Microbiol (2010) 0.87
Curcumin-loaded hydrogel nanoparticles: application in anti-malarial therapy and toxicological evaluation. J Pharm Sci (2010) 0.87
Shape anisotropy induces rotations in optically trapped red blood cells. J Biomed Opt (2010) 0.86
Arrest of nuclear division in Plasmodium through blockage of erythrocyte surface exposed ribosomal protein P2. PLoS Pathog (2012) 0.86
Surface functionalized amorphous nanosilica and microsilica with nanopores as promising tools in biomedicine. Naturwissenschaften (2008) 0.85
Age-dependent sex bias in clinical malarial disease in hypoendemic regions. PLoS One (2012) 0.85
Metabolic fingerprints of serum, brain, and liver are distinct for mice with cerebral and noncerebral malaria: a ¹H NMR spectroscopy-based metabonomic study. J Proteome Res (2012) 0.85
Global host metabolic response to Plasmodium vivax infection: a 1H NMR based urinary metabonomic study. Malar J (2011) 0.85
Surface-modified sulfur nanoparticles: an effective antifungal agent against Aspergillus niger and Fusarium oxysporum. Appl Microbiol Biotechnol (2011) 0.84
Solid microemulsion preconcentrate (NanOsorb) of artemether for effective treatment of malaria. Int J Pharm (2008) 0.84
Multivariate modelling with (1)H NMR of pleural effusion in murine cerebral malaria. Malar J (2011) 0.83
Biochemical-, biophysical-, and microarray-based antifungal evaluation of the buffer-mediated synthesized nano zinc oxide: an in vivo and in vitro toxicity study. Langmuir (2012) 0.83
Nanoparticle-induced morphological transition of Bombyx mori nucleopolyhedrovirus: a novel method to treat silkworm grasserie disease. Appl Microbiol Biotechnol (2013) 0.82
Functional complementation of yeast ribosomal P0 protein with Plasmodium falciparum P0. Gene (2005) 0.81
How specific is the immune response to malaria in adults living in endemic areas? J Vector Borne Dis (2004) 0.81
Metabolic perturbations of kidney and spleen in murine cerebral malaria: (1)H NMR-based metabolomic study. PLoS One (2013) 0.81
Tissue-specific gene silencing monitored in circulating RNA. RNA (2013) 0.81
Polyethylene glycol-stabilized sulphur nanoparticles: an effective antimicrobial agent against multidrug-resistant bacteria. J Antimicrob Chemother (2012) 0.81
Inhibitory effects of sulfur nanoparticles on membrane lipids of Aspergillus niger: a novel route of fungistasis. Curr Microbiol (2012) 0.81
Photochemical modulation of biosafe manganese nanoparticles on Vigna radiata: a detailed molecular, biochemical, and biophysical study. Environ Sci Technol (2013) 0.81
Formulation and characterization of atovaquone nanosuspension for improved oral delivery in the treatment of malaria. Nanomedicine (Lond) (2013) 0.81
Nanoparticle-virus complex shows enhanced immunological effect against baculovirus. J Nanosci Nanotechnol (2009) 0.81
Plant-like phosphofructokinase from Plasmodium falciparum belongs to a novel class of ATP-dependent enzymes. Int J Parasitol (2009) 0.80
Tank treading of optically trapped red blood cells in shear flow. Biophys J (2011) 0.80
Nanoparticle surface as activation site. J Nanosci Nanotechnol (2010) 0.80
Translocation of ribosomal protein P0 onto the Toxoplasma gondii tachyzoite surface. Int J Parasitol (2003) 0.80
Comparison of different silicas of natural origin as possible insecticides. Commun Agric Appl Biol Sci (2008) 0.78
Identification of a hypothetical membrane protein interactor of ribosomal phosphoprotein P0. J Biosci (2004) 0.78
Clotrimazole nanoemulsion for malaria chemotherapy. Part I: preformulation studies, formulation design and physicochemical evaluation. Int J Pharm (2011) 0.78
On the birefringence of healthy and malaria-infected red blood cells. J Biomed Opt (2013) 0.78
Generation and characterisation of monoclonal antibodies specific to Plasmodium falciparum enolase. J Vector Borne Dis (2006) 0.78
Comparative analysis of stability and toxicity profile of three differently capped gold nanoparticles for biomedical usage. Biometals (2012) 0.78
Nature-inspired novel drug design paradigm using nanosilver: efficacy on multi-drug-resistant clinical isolates of tuberculosis. Curr Microbiol (2010) 0.78
Liver Metabolic Alterations and Changes in Host Intercompartmental Metabolic Correlation during Progression of Malaria. J Parasitol Res (2011) 0.77
Study of P. falciparum-infected erythrocytes and induced anisotropies under optical and fluid forces. J Vector Borne Dis (2007) 0.77
Host responses in malaria disease evaluated through nuclear magnetic resonance-based metabonomics. Clin Lab Med (2012) 0.77
Erythrocytic stage-dependent regulation of oligomerization of Plasmodium ribosomal protein P2. J Biol Chem (2012) 0.77
Mechanical downsizing of a gadolinium(III)-based metal-organic framework for anticancer drug delivery. Chemistry (2014) 0.76
NMR insights into folding and self-association of Plasmodium falciparum P2. PLoS One (2012) 0.76
Manganese nanoparticles: impact on non-nodulated plant as a potent enhancer in nitrogen metabolism and toxicity study both in vivo and in vitro. J Agric Food Chem (2014) 0.76
Self-microemulsifiyng suppository formulation of β-artemether. AAPS PharmSciTech (2010) 0.76
1H NMR metabonomics indicates continued metabolic changes and sexual dimorphism post-parasite clearance in self-limiting murine malaria model. PLoS One (2013) 0.75
Evolution of nanoparticle-induced distortion on viral polyhedra. J Biol Phys (2013) 0.75
Plasmodium riboprotein PfP0 induces a deviant humoral immune response in Balb/c mice. J Biomed Biotechnol (2012) 0.75
Residue level description of in vivo self-association of Plasmodium falciparum P2. J Biomol Struct Dyn (2013) 0.75
Entomotoxicity and biosafety assessment of PEGylated acephate nanoparticles: a biologically safe alternative to neurotoxic pesticides. J Environ Sci Health B (2013) 0.75
Effect of Nanohexaconazole on Nitrogen Fixing Blue Green Algae and Bacteria. J Nanosci Nanotechnol (2016) 0.75
Expedition of in vitro dissolution and in vivo pharmacokinetic profiling of sulfur nanoparticles based antimicrobials. Environ Toxicol Pharmacol (2013) 0.75
Fabrication of multi-structure nanocarbons from carbon xerogel: a unique scaffold towards bio-imaging. Chem Commun (Camb) (2011) 0.75
Clotrimazole nanoemulsion for malaria chemotherapy. Part II: stability assessment, in vivo pharmacodynamic evaluations and toxicological studies. Int J Pharm (2012) 0.75
Evaluation of novel lipid based formulation of β-Artemether and Lumefantrine in murine malaria model. Int J Pharm (2013) 0.75
High throughput electron transfer from carbon dots to chloroplast: a rationale of enhanced photosynthesis. Nanoscale (2014) 0.75
Intravenous β-artemether formulation (ARM NLC) as a superior alternative to commercial artesunate formulation. J Antimicrob Chemother (2012) 0.75
Underlying mathematics in diversification of human olfactory receptors in different loci. Interdiscip Sci (2014) 0.75
Designing exons for human olfactory receptor gene subfamilies using a mathematical paradigm. J Biosci (2010) 0.75
The C-terminal domain of eukaryotic acidic ribosomal P2 proteins is intrinsically disordered with conserved structural propensities. Protein Pept Lett (2014) 0.75
DNA sequence evolution through Integral Value Transformations. Interdiscip Sci (2012) 0.75
Development and Quality Control of Nanohexaconazole as an Effective Fungicide and Its Biosafety Studies on Soil Nitifiers. J Nanosci Nanotechnol (2015) 0.75
152 Molten globule behavior of apicomplexan protein P2 from Plasmodium falciparum and Toxoplasma gondii. J Biomol Struct Dyn (2015) 0.75
Investigation of antimicrobial physiology of orthorhombic and monoclinic nanoallotropes of sulfur at the interface of transcriptome and metabolome. Appl Microbiol Biotechnol (2013) 0.75